Andrew Brenner

Andrew Brenner is a scientific advisor at Plus Therapeutics. Andrew has also worked as a postdoctoral fellow at the European Institute of Oncology, NanoTx Therapeutics, and MD Anderson Cancer Center Science Park. Their research has focused on cell cycle abnormalities in breast neoplasms.

Dr. Andrew Brenner is a graduate of Texas A&M University, where they earned their Bachelor of Science in Biochemistry. Andrew then attended The University of Texas at Austin to earn their Doctorate in Tumor Biology. After completing their doctorate, they attended Texas Tech University Health Sciences Center - School of Medicine to earn their M.D. Andrew is also certified by the United College for Neurologic Subspecialties in Neuro-Oncology and by the American Board of Internal Medicine in Medical Oncology and Internal Medicine.